Mays Aqrouq

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Montpellier GenomiX(Current)

Institut de Génétique Moléculaire de Montpellier

Centre National de la Recherche Scientifique

Université de Montpellier

Inserm

Mays Aqrouq is an author at Montpellier GenomiX specializing in oncology, chemotherapy in hematologic malignancies, and hematologic malignancy therapy.

ORCID

Publications per year

2023–2023

Publications

SUMOylation inhibitor TAK-981 (subasumstat) synergizes with 5-azacitidine in preclinical models of acute myeloid leukemia

Ludovic Gabellier, Marion de Toledo, Mehuli Chakraborty et al. · Haematologica · 2023 · 18 citations · Full text

Medicine, Oncology, Pharmacology +15

DeSUMOylation of chromatin-bound proteins limits the rapid transcriptional reprogramming induced by daunorubicin in acute myeloid leukemias

Mathias Boulanger, Mays Aqrouq, Denis Tempé et al. · Nucleic Acids Research · 2023 · 11 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–2 of 2